CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,310,361
- in 7 filings, $252K under 10b5-1 plans
Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$112K Chief Operating Officer sold 7% of stake
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2023-05-31 | Collins Helen Louise Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2023-02-16 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +10,625 | 27,466 | ||
| 2023-02-16 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award · Option to purchase common stock | +63,750 | 63,750 | ||
| 2023-02-16 | Bair Teresa Brophy Chief Legal Officer | Grant or award | +23,125 | 23,125 | ||
| 2023-02-16 | Bair Teresa Brophy Chief Legal Officer | Grant or award · Option to purchase common stock | +138,750 | 138,750 | ||
| 2023-02-16 | FORD KATHLEEN Chief Operating Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2023-02-16 | DALE STEPHEN Chief Medical Officer | Grant or award | +23,125 | 50,800 | ||
| 2023-02-16 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2023-02-16 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +560,000 | 560,000 | ||
| 2023-01-27 | FORD KATHLEEN Chief Operating Officer | Sale | −1,821 | $13.89 | $25K | 21,214 |
| 2023-01-27 | FLOWERS KIRSTEN CCO & Chief Strategy Officer | Sale | −1,906 | $13.89 | $26K | 20,605 |
| 2023-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −682 | $13.89 | $9K | 17,707 |
| 2023-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −866 | $13.89 | $12K | 16,841 |
| 2023-01-27 | DALE STEPHEN Chief Medical Officer | Sale | −4,385 | $13.89 | $61K | 32,515 |
| 2023-01-27 | DALE STEPHEN Chief Medical Officer | Sale | −4,840 | $13.87 | $67K | 27,675 |
| 2022-11-17 | Bair Teresa Brophy Chief Legal Officer | Sale | −2,100 | $15.22 | $32K | 0 |
| 2022-10-06 | WILSON TROY EDWARD President and CEO | Other disposition | −1,084,300 | 8,394 | ||
| 2022-10-06 | WILSON TROY EDWARD President and CEO | Other acquisition | +1,084,300 | 1,125,618 | ||
| 2022-08-19 | WILSON TROY EDWARD President and CEO | Other disposition | −17,708 | 1,134,012 |
Page 10 of 19 · 366 trades